Nature Biotechnology, volume 38, issue 11, pages 1242-1252
COVID-19 antibodies on trial
1
Senior editor, Nature Biotechnology
Publication type: Journal Article
Publication date: 2020-10-21
Journal:
Nature Biotechnology
Q1
Q1
SJR: 18.117
CiteScore: 63.0
Impact factor: 33.1
ISSN: 10870156, 15461696
Molecular Medicine
Applied Microbiology and Biotechnology
Biotechnology
Bioengineering
Biomedical Engineering
Abstract
With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
Found
Found
Top-30
Journals
|
1
2
3
4
5
|
|
|
Scientific Reports
5 publications, 5.15%
|
|
|
Frontiers in Immunology
3 publications, 3.09%
|
|
|
Antiviral Research
3 publications, 3.09%
|
|
|
Viruses
2 publications, 2.06%
|
|
|
Nature
2 publications, 2.06%
|
|
|
Vaccine
2 publications, 2.06%
|
|
|
Nature Communications
2 publications, 2.06%
|
|
|
Current Molecular Medicine
1 publication, 1.03%
|
|
|
Pharmacological Reports
1 publication, 1.03%
|
|
|
Cells
1 publication, 1.03%
|
|
|
Molecules
1 publication, 1.03%
|
|
|
Vaccines
1 publication, 1.03%
|
|
|
Life
1 publication, 1.03%
|
|
|
International Journal of Molecular Sciences
1 publication, 1.03%
|
|
|
Frontiers in Molecular Biosciences
1 publication, 1.03%
|
|
|
Frontiers in Pharmacology
1 publication, 1.03%
|
|
|
Pharmaceutical Medicine
1 publication, 1.03%
|
|
|
Microbial Cell Factories
1 publication, 1.03%
|
|
|
Cell and Bioscience
1 publication, 1.03%
|
|
|
Journal of Microbiology
1 publication, 1.03%
|
|
|
Current Transplantation Reports
1 publication, 1.03%
|
|
|
Molecular Biology Reports
1 publication, 1.03%
|
|
|
Pharmaceutical Research
1 publication, 1.03%
|
|
|
Nature Medicine
1 publication, 1.03%
|
|
|
Cell Chemical Biology
1 publication, 1.03%
|
|
|
Virologica Sinica
1 publication, 1.03%
|
|
|
Acta Pharmaceutica Sinica B
1 publication, 1.03%
|
|
|
BioScience Trends
1 publication, 1.03%
|
|
|
BMC Health Services Research
1 publication, 1.03%
|
|
|
1
2
3
4
5
|
Publishers
|
2
4
6
8
10
12
14
16
18
|
|
|
Springer Nature
18 publications, 18.56%
|
|
|
Cold Spring Harbor Laboratory
17 publications, 17.53%
|
|
|
Elsevier
14 publications, 14.43%
|
|
|
Wiley
8 publications, 8.25%
|
|
|
MDPI
7 publications, 7.22%
|
|
|
Frontiers Media S.A.
6 publications, 6.19%
|
|
|
Taylor & Francis
4 publications, 4.12%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 2.06%
|
|
|
American Chemical Society (ACS)
2 publications, 2.06%
|
|
|
Oxford University Press
2 publications, 2.06%
|
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 2.06%
|
|
|
Han-Gug Misaengmul Hag-hoe/The Microbiological Society of Korea
1 publication, 1.03%
|
|
|
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
1 publication, 1.03%
|
|
|
American Society for Biochemistry and Molecular Biology
1 publication, 1.03%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.03%
|
|
|
American Society for Microbiology
1 publication, 1.03%
|
|
|
European Molecular Biology Organization
1 publication, 1.03%
|
|
|
Korea Genome Organization
1 publication, 1.03%
|
|
|
Heighten Science Publications Corporation
1 publication, 1.03%
|
|
|
Federal Medical Biological Agency
1 publication, 1.03%
|
|
|
IntechOpen
1 publication, 1.03%
|
|
|
Higher Education Press
1 publication, 1.03%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.03%
|
|
|
Eco-Vector LLC
1 publication, 1.03%
|
|
|
2
4
6
8
10
12
14
16
18
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/s41587-020-0732-8
UR - https://doi.org/10.1038/s41587-020-0732-8
TI - COVID-19 antibodies on trial
T2 - Nature Biotechnology
AU - Defrancesco, Laura
PY - 2020
DA - 2020/10/21
PB - Springer Nature
SP - 1242-1252
IS - 11
VL - 38
SN - 1087-0156
SN - 1546-1696
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Defrancesco,
author = {Laura Defrancesco},
title = {COVID-19 antibodies on trial},
journal = {Nature Biotechnology},
year = {2020},
volume = {38},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1038/s41587-020-0732-8},
number = {11},
pages = {1242--1252},
doi = {10.1038/s41587-020-0732-8}
}
Cite this
MLA
Copy
Defrancesco, Laura. “COVID-19 antibodies on trial.” Nature Biotechnology, vol. 38, no. 11, Oct. 2020, pp. 1242-1252. https://doi.org/10.1038/s41587-020-0732-8.